LOGOLOGOLOGOLOGO
  • About us
    • Who we are
      • Governance
      • Staff
      • Vacancies
    • What we do
  • Members
    • EuropaBio Members
    • About Membership
  • How we work
    • Healthcare Biotechnology Council
      • Cell & Gene Therapies
      • Medicines For Rare Diseases And Children
      • Regulatory Efficiency
      • Biosimilars & Public Procurement
      • Data & Digital
      • Patient Bio-Forum
    • Industrial Biotechnology Council
      • Food, Feed & Nutrition
      • Circular Bioeconomy
    • National Associations Council
    • SME Platform
    • Biomanufacturing Platform
  • Activities
    • 25 Years of Innovation
    • EFIB 2022
    • European Biotech Week
  • News & Events
    • News
    • Events
  • Library
Become a member
✕

Abolis joins EuropaBio: Sustainable Bio-Based Products

15/03/2021
PRESS RELEASE

Abolis joins EuropaBio: Sustainable Bio-Based Products

Brussels, 15 March 2021 – EuropaBio is pleased to announce that Abolis has joined as a Corporate member.

Abolis, from its head office near Paris, is at the forefront of the European development and manufacture of bio-based products for clients worldwide. It offers a combination of advanced genetic technologies, microbial biodiversity and bioinformatics capabilities to produce, via fermentation, a wide portfolio of complex molecules for food & feed, cosmetics, flavours & fragrances, specialty chemicals and pharmaceuticals.

It serves the rapidly expanding demand for bio-based products to replace conventionally produced chemicals and ingredients. Working closely with clients and partners, Abolis helps to establish technical and economic feasibility of a switch to bio-based, optimises the inner workings of micro-organisms’ metabolism and integrates downstream aspects of industrialisation from the first stages of development, as well as to enable novel branches of (bio)chemistry towards novel molecules and functionalities.

EuropaBio Director-General Dr. Claire Skentelbery commented “Abolis shows us the pathway forwards for European innovation from industrial biotechnology across all sectors. The company is a valuable addition to the EuropaBio community, as a rapidly expanding SME with global reach.”

Abolis CEO Cyrille Pauthenier added “As a fast-growing biotech company in the past years we have invested extensively into internal and proprietary technologies and know-how, established deep industrial relations and satisfied our first clients by reaching significant milestones. We are now more than happy to join EuropaBio, as part of our strategy to become the European leader in the field, by extending our network of industrial partnerships and product development pipeline to a broader pan-European audience.”

Download the full PRESS RELEASE below.

Abolis Joins EuropaBio: Sustainable Bio-Based Products


Download
2021_03_G_PR_Abolis_joins_EuropaBio-1Download
Share
Alexandra Simionca
Alexandra Simionca

Related posts

18/09/2023

Genopole joins EuropaBio: French biotechnology on a global scale


Read more
14/09/2023

Revision of the Detergents Regulation: EuropaBio policy asks for Microbial-based Cleaning Products


Read more
14/09/2023

European Commission proposal on New Genomic Techniques – a first step towards modernizing the EU GMO framework


Read more

Important links

  • Genopole joins EuropaBio: French biotechnology on a global scale
  • Revision of the Detergents Regulation: EuropaBio policy asks for Microbial-based Cleaning Products

Categories in our Newsroom

Subscribe for our newsletter

Subscribe to the EuropaBio newsletter to receive the latest news and developments in the Biotech sector!


Subscribe
LOGO-white

EuropaBio represents corporate and associate members across sectors, plus national and regional biotechnology associations which, in turn, represent over 2600 biotech companies, 2300 out of them are SMEs.

Contact us

Extra links

Members
Staff
Privacy policy
Legal & cookies
Events
Newsroom

Become a member

Media pack

© 2023 Europabio. All Rights Reserved. Designed by EYAS
Become a member